Magyar
Toggle navigation
Tudóstér
Magyar
Tudóstér
Keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Böngészés
Saját polc tartalma
(
0
)
Korábbi keresések
CCL parancs
CCL
Összesen 12 találat.
#/oldal:
12
36
60
120
Rövid
Hosszú
MARC
Részletezés:
Rendezés:
Szerző növekvő
Szerző csökkenő
Cím növekvő
Cím csökkenő
Dátum növekvő
Dátum csökkenő
1.
001-es BibID:
BIBFORM077074
Első szerző:
Bajor Judit
Cím:
HLA-DQ2 homozygosis increases tTGA levels at diagnosis but does not influence the clinical phenotype of celiac disease : a multicenter study / Bajor Judit, Szakacs Zsolt, Juhasz Mark, Papp Maria, Kocsis Dorottya, Szegedi Eva, Foldi Ildiko, Farkas Nelli, Hegyi Peter, Vincze Aron
Dátum:
2019
ISSN:
1744-3121 1744-313X
Megjegyzések:
Background and purpose: Magnitude of gluten-specific T-cell responses in celiac disease might be dependent on HLA-DQ2 gene dose. We aimed to investigate the effects of HLA-DQB1*02 allele dose on clinical outcomes. Methods: We reviewed the charts of all celiac patients attending to three Hungarian university clinics after 1997 and included those patients, who 1) were diagnosed with celiac disease, 2) underwent high resolution HLA-typing, and 3) were ?18 years at the time of data collection. HLA typing was performed to determine DQB1*02 allele dose. Patients were divided into risk groups by DQB1*02 allele dose, as follows: high-, intermediate-, and low-risk groups corresponded to a double, single, and zero doses, respectively. We used ANOVA and Person's chi-squared test to explore association between HLA-risk and clinical variables. Results: 727 celiac patients attended the clinics but only 105 (14.4%) patients were eligible for inclusion. High, intermediate, and low HLA-risk patients comprised 35.3%, 52.3%, and 12.3% of the study population, respectively. Double dose of HLADQB1*02 was more frequent in patient with high tTGA level (> 10 times the upper limit of normal) (p=0.045). Gene dose was not associated with younger age at diagnosis (p=0.549), gender (p=0.739), more severe diagnostic histology (p=0.318), more frequent classical presentation (p=0.846), anemia (p=0.611), metabolic bone disease (p=0.374), dermatitis herpetiformis (p=0.381), and autoimmune diseases (p=0.837). Conclusions: Our study shows a significant gene dose effect in terms of tTGA level at diagnosis, but no significant association between HLA-DQB1*02 allele dose and the clinical outcomes in celiac disease.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:
International Journal of Immunogenetics. - 46 : 2 (2019), p. 74-81. -
További szerzők:
Szakács Zsolt
Juhász Márk Félix
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Kocsis Dorottya
Szegedi Éva
Földi Ildikó (1981-) (orvos)
Farkas Nelli
Hegyi Péter Jenő (belgyógyász)
Vincze Áron
Pályázati támogatás:
ÚNKP-17-3-II
ÚNKP
Internet cím:
Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:
Saját polcon:
2.
001-es BibID:
BIBFORM083118
Első szerző:
Bor Renáta
Cím:
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease : a nationwide Hungarian cohort study / Bor Renáta, Fábián Anna, Matuz Mária, Szepes Zoltán, Farkas Klaudia, Miheller Pál, Szamosi Tamás, Vincze Áron, Rutka Mariann, Szántó Kata, Bálint Anita, Nagy Ferenc, Milassin Ágnes, Tóth Tibor, Zsigmond Ferenc, Bajor Judit, Müllner Katalin, Lakner Lilla, Papp Mária, Salamon Ágnes, Horváth Gábor, Sarang Krisztina, Schäfer Eszter, Sarlós Patrícia, Palatka Károly, Molnár Tamás
Dátum:
2020
ISSN:
1471-2598
Megjegyzések:
ABSTRACT Background: GEMINI trials demonstrated the therapeutic efficacy of vedolizumab (VDZ) in Crohn's disease (CD) and ulcerative colitis (UC). Research design and methods: Aim of this study was to determine the real-life effectiveness of VDZ on endoscopic healing in the Hungarian nationwide cohort of inflammatory bowel disease (IBD) patients based on the changes on clinical and endoscopic scores. Every adult IBD patient in the country (121 UC and 83 CD) who completed the short-term VDZ therapy was enrolled, of which 72 UC and 52 CD patients could complete the long-term therapy. Results: The rates of endoscopic healing were substantially higher in UC compared with CD patients during the short- and long-term therapy (52.9% vs. 21.7%, p < 0.0001, and 51.4% vs. 21.2%, p = 0.015, respectively). In CD, the rate of endoscopic healing was lower at week 14 compared with week 22 (14.5% vs. 37.0%, p = 0.026). Prior anti-TNF-? therapy (88.73%) was not associated with a significant decrease in therapeutic response. The average disease duration was significantly lower in CD patients achieving endoscopic healing at week 52 (11.75 vs. 5.27 years, p = 0.007). Conclusions: VDZ therapy is an effective therapeutic option in anti-TNF-? refractory IBD. However, the endoscopic healing rate was substantially lower and showed a significant delay in CD compared with UC.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Crohn's disease
ulcerative colitis
VDZ
vedolizumab
IBD
Megjelenés:
Expert Opinion On Biological Therapy. - 20 : 2 (2020), p. 205-213. -
További szerzők:
Fábián Anna
Matuz Mária
Szepes Zoltán
Farkas Klaudia
Miheller Pál
Szamosi Tamás
Vincze Áron
Rutka Mariann
Szántó Kata
Bálint Anita
Nagy Ferenc (orvos Szeged)
Milassin Ágnes
Tóth Tibor
Zsigmond Ferenc
Bajor Judit
Müllner Katalin (Budapest)
Lakner Lilla
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Salamon Ágnes (orvos Szekszárd)
Horváth Gábor (orvos Miskolc)
Sarang Krisztina
Schafer Eszter
Sarlós Patrícia
Palatka Károly (1961-) (belgyógyász, gasztroenterológus)
Molnár Tamás (orvos Szeged)
Pályázati támogatás:
EFOP-3.6.2-16-2017-00006
EFOP
119809
OTKA
125377
OTKA
129266
OTKA
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
3.
001-es BibID:
BIBFORM088207
Első szerző:
Demcsák Alexandra
Cím:
Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study / Alexandra Demcsak, Alexandra Soos, Lilla Kincses, Ines Capunge, Georgi Minkov, Mila Kovacheva-Slavova, Radislav Nakov, Dong Wu, Wei Huang, Qing Xia, Lihui Deng, Marcus Hollenbach, Alexander Schneider, Michael Hirth, Orestis Ioannidis, Aron Vincze, Judit Bajor, Patrícia Sarlos, Laszló Czakó, Dora Illés, Ferenc Izbeki, Laszló Gajdán, Maria Papp, Jozsef Hamvas, Marta Varga, Peter Kanizsai, Ernő Bóna, Alexandra Miko, Szilard Váncsa, Márk Félix Juhász, Klementina Ocskay, Erika Darvasi, Emőke Miklós, Balint Erőss, Andrea Szentesi, Andrea Parniczky, Riccardo Casadei, Claudio Ricci, Carlo Ingaldi, Laura Mastrangelo, Elio Jovine, Vincenzo Cennamo, Marco V. Marino, Giedrius Barauskas, Povilas Ignatavicius, Mario Pelaez-Luna, Andrea Soriano Rios, Svetlana Turcan, Eugen Tcaciuc, Ewa Małecka-Panas, Hubert Zatorski, Vitor Nunes, Antonio Gomes, Tiago Cúrdia Gonçalves, Marta Freitas, Júlio Constantino, Milene Sa, Jorge Pereira, Bogdan Mateescu, Gabriel Constantinescu, Vasile Sandru, Ionut Negoi, Cezar Ciubotaru, Valentina Negoita, Stefania Bunduc, Cristian Gheorghe, Sorin Barbu, Alina Tantau, Marcel Tantau, Eugen Dumitru, Andra Iulia Suceveanu, Cristina Tocia, Adriana Gherbon, Andrey Litvin, Natalia Shirinskaya, Yliya Rabotyagova, Mihailo Bezmarevic, Péter Jenő Hegyi, Jimin Han, Juan Armando Rodriguez-Oballe, Isabel Miguel Salas, Eva Pijoan Comas, Daniel de la Iglesia Garcia, Andrea Jardi Cuadrado, Adriano Quiroga Castineira, Yu-Ting Chang, Ming-Chu Chang, Ali Kchaou, Ahmed Tlili, Sabite Kacar, Volkan Gokbulut, Deniz Duman, Haluk Tarik Kani, Engin Altintas, Serge Chooklin, Serhii Chuklin, Amir Gougol, George Papachristou, Peter Hegyi Jr.
Dátum:
2020
ISSN:
1424-3903
Megjegyzések:
Background:Acid suppressing drugs (ASD) are generally used in acute pancreatitis (AP); however, largecohorts are not available to understand their efficiency and safety. Therefore, our aims were to evaluatethe association between the administration of ASDs, the outcome of AP, the frequency of gastrointestinal(GI) bleeding and GI infection in patients with AP.Methods:We initiated an international survey and performed retrospective data analysis on AP patientshospitalized between January 2013 and December 2018.Results:Data of 17,422 adult patients with AP were collected from 59 centers of 23 countries. We foundthat 23.3% of patients received ASDs before and 86.6% during the course of AP. ASDs were prescribed to57.6% of patients at discharge. ASD administration was associated with more severe AP and highermortality. GI bleeding was reported in 4.7% of patients, and it was associated with pancreatitis severity,mortality and ASD therapy. Stool culture test was performed in 6.3% of the patients with 28.4% positiveresults.Clostridium difficilewas the cause of GI infection in 60.5% of cases. Among the patients with GIinfections, 28.9% received ASDs, whereas 24.1% were without any acid suppression treatment. GI infec-tion was associated with more severe pancreatitis and higher mortality.Conclusions:Although ASD therapy is widely used, it is unlikely to have beneficial effects either on theoutcome of AP or on the prevention of GI bleeding during AP. Therefore, ASD therapy should be sub-stantially decreased in the therapeutic management of AP.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Acid suppressing drug
Gastrointestinal bleeding
Gastrointestinal infection
Acute pancreatitis
Proton pump inhibitor
Megjelenés:
Pancreatology. - 20 : 7 (2020), p. 1323-1331. -
További szerzők:
Soós Alexandra
Kincses Lilla
Capunge, Ines
Minkov, Georgi
Kovacheva-Slavova, Mila
Nakov, Radislav
Wu, Dong
Huang, Wei
Xia, Qing
Deng, Lihui
Hollenbach, Marcus
Schneider, Alexander
Hirth, Michael
Ioannidis, Orestis
Vincze Áron
Bajor Judit
Sarlós Patrícia
Czakó László
Illés Dóra
Izbéki Ferenc
Gajdán László
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Hamvas József
Varga Márta
Kanizsai Péter
Bóna Ernő
Mikó Alexandra
Váncsa Szilárd
Juhász Márk Félix
Ocskay Klementina
Darvasi Erika
Miklós Emőke
Erőss Bálint
Szentesi Andrea
Párniczky Andrea (gyermekgyógyász)
Casadei, Riccardo
Ricci, Claudio
Ingaldi, Carlo
Mastrangelo, Laura
Jovine, Elio
Cennamo, Vincenzo
Marino, Marco Vito
Barauskas, Giedrius
Ignatavicius, Povilas
Pelaez-Luna, Mario
Rios, Andrea Soriano
Turcan, Svetlana
Tcaciuc, Eugen
Małecka-Panas, Ewa
Zatorski, Hubert
Nunes, Vitor
Gomes, António Pedro
Gonçalves, Tiago Cúrdia
Freitas, Marta
Constantino, Júlio
Sá, Milene
Pereira, Jorge
Mateescu, Bogdan
Constantinescu, Gabriel
Sandru, Vasile
Negoi, Ionut
Ciubotaru, Cezar
Negoita, Valentina
Bunduc, Stefania
Gheorghe, Cristian
Barbu, Sorin
Tantau, Alina
Tantau, Marcel
Dumitru, Eugen
Suceveanu, Andra Iulia
Tocia, Cristina
Gherbon, Adriana
Litvin, A. Andrey
Shirinskaya, Natalia V.
Rabotyagova, Yliya
Bezmarevic, Mihailo
Hegyi Péter Jenő (belgyógyász)
Han, Jimin
Rodriguez-Oballe, Juan Armando
Salas, Isabel Miguel
Comas, Eva Pijoan
Garcia, Daniel de la Iglesia
Cuadrado, Andrea Jardi
Castiñeira, Adriano Quiroga
Chang, Yu-Ting
Chang, Ming-Chu
Kchaou, Ali
Tlili, Ahmed
Kacar, Sabite
Gökbulut, Volkan
Duman, Deniz
Kani, Haluk Tarik
Altintas, Engin
Chooklin, Serge
Chuklin, Serhii
Gougol, Amir
Papachristou, Georgios I.
Hegyi Péter Jr. (belgyógyász)
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
4.
001-es BibID:
BIBFORM082673
035-os BibID:
(cikkazonosító)1092 (WoS)000483784200001 (Scopus)85072948362
Első szerző:
Farkas Nelli
Cím:
A Multicenter, International Cohort Analysis of 1435 Cases to Support Clinical Trial Design in Acute Pancreatitis / Nelli Farkas, Lilla Hanák, Alexandra Mikó, Judit Bajor, Patrícia Sarlós, József Czimmer, Áron Vincze, Szilárd Gódi, Dániel Pécsi, Péter Varjú, Katalin Márta, Péter Jenő Hegyi, Bálint Erőss, Zsolt Szakács, Tamás Takács, László Czakó, Balázs Németh, Dóra Illés, Balázs Kui, Erika Darvasi, Ferenc Izbéki, Adrienn Halász, Veronika Dunás-Varga, László Gajdán, József Hamvas, Mária Papp, Ildikó Földi, Krisztina Eszter Fehér, Márta Varga, Klára Csefkó, Imola Török, Farkas Hunor-Pál, Artautas Mickevicius, Elena Ramirez Maldonado, Ville Sallinen, János Novák, Ali Tüzün Ince, Shamil Galeev, Barnabás Bod, János Sümegi, Petr Pencik, Attila Szepes, Andrea Szentesi, Andrea Párniczky, Péter Jr. Hegyi, Hungarian Pancreatic Study Group
Dátum:
2019
ISSN:
1664-042X
Megjegyzések:
Background: C-reactive protein level (CRP) and white blood cell count (WBC) have been variably used in clinical trials on acute pancreatitis (AP). We assessed their potential role. Methods: First, we investigated studies which have used CRP or WBC, to describe their current role in trials on AP. Second, we extracted the data of 1435 episodes of AP from our registry. CRP and WBC on admission, within 24 h from the onset of pain and their highest values were analyzed. Descriptive statistical tools as Kruskal?Wallis, Mann? Whitney U, Levene's F tests, Receiver Operating Characteristic (ROC) curve analysis and AUC (Area Under the Curve) with 95% confidence interval (CI) were performed. Results: Our literature review showed extreme variability of CRP used as an inclusion criterion or as a primary outcome or both in past and current trials on AP. In our cohort, CRP levels on admission poorly predicted mortality and severe cases of AP; AUC: 0.669 (CI:0.569?0.770); AUC:0.681 (CI: 0.601?0.761), respectively. CRP levels measured within 24 h from the onset of pain failed to predict mortality or severity; AUC: 0.741 (CI:0.627?0.854); AUC:0.690 (CI:0.586?0.793), respectively. The highest CRP during hospitalization had equally poor predictive accuracy for mortality and severity AUC:0.656 (CI:0.544?0.768); AUC:0.705 (CI:0.640?0.769) respectively. CRP within 24 h from the onset of pain used as an inclusion criterion markedly increased the combined event rate of mortality and severe AP (13% for CRP > 25 mg/l and 28% for CRP > 200 mg/l). Conclusion: CRP within 24 h from the onset of pain as an inclusion criterion elevates event rates and reduces the number of patients required in trials on AP.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
acute pancreatitis
C-reactive protein
white blood cell
trial design
sample size calculation
Megjelenés:
Frontiers in Physiology. - 10 (2019), p. 1-12. -
További szerzők:
Hanák Lilla
Mikó Alexandra
Bajor Judit
Sarlós Patrícia
Czimmer József
Vincze Áron
Gódi Szilárd
Pécsi Dániel
Varjú Péter
Márta Katalin
Hegyi Péter Jenő (belgyógyász)
Erőss Bálint
Szakács Zsolt
Takács Tamás (Szeged)
Czakó László
Németh Balázs Tamás
Illés Dóra
Kui Balázs
Darvasi Erika
Izbéki Ferenc
Halász Adrienn
Dunás-Varga Veronika
Gajdán László
Hamvas József
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Földi Ildikó (1981-) (orvos)
Fehér Krisztina Eszter
Varga Márta
Csefkó Klára
Török Imola
Farkas Hunor
Mickevicius, Artautas
Maldonado, Elena Ramirez
Sallinen, Ville
Novák János
Ince, Ali Tüzün
Galeev, Shamil
Bod Barnabás
Sümegi János
Pencik, Petr
Szepes Attila (Szeged)
Szentesi Andrea
Párniczky Andrea (gyermekgyógyász)
Hegyi Péter Jr. (belgyógyász)
Hungarian Pancreatic Study Group
Pályázati támogatás:
GINOP 2.3.2-15-2016-00048
GINOP
EFOP-3.6.2-16-2017-00006
EFOP
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
5.
001-es BibID:
BIBFORM090160
035-os BibID:
(cikkazonosító)1367 (WOS)000626774100081 (Scopus)85099483306
Első szerző:
Hegyi Péter Jr. (belgyógyász)
Cím:
Evidence for diagnosis of early chronic pancreatitis after three episodes of acute pancreatitis : a cross-sectional multicentre international study with experimental animal model / Péter J. Hegyi, Alexandra Soós, Emese Tóth, Attila Ébert, Viktória Venglovecz, Katalin Márta, Péter Mátrai, Alexandra Mikó, Judit Bajor, Patrícia Sarlós, Áron Vincze, Adrienn Halász, Ferenc Izbéki, Zoltán Szepes, László Czakó, György Kovács, Mária Papp, Zsolt Dubravcsik, Márta Varga, József Hamvas, Balázs C. Németh, Melania Macarie, Ali Tüzüm Ince, Elena A. Dubtsova, Mariya A. Kirynkova, Igor E. Khatkov, Tanya Bideeva, Artautas Mickevicius, Elena Ramírez-Maldonado, Ville Sallinen, Bálint Erős, Dániel Pécsi, Andrea Szentesi, Andrea Párniczky, László Tiszlavicz, Péter Hegyi
Dátum:
2021
ISSN:
2045-2322
Megjegyzések:
Abstract Chronic pancreatitis (CP) is an end-stage disease with no specific therapy; therefore, an early diagnosis is of crucial importance. In this study, data from 1315 and 318 patients were analysed from acute pancreatitis (AP) and CP registries, respectively. The population from the AP registry was divided into AP (n = 983), recurrent AP (RAP, n = 270) and CP (n = 62) groups. The prevalence of CP in combination with AP, RAP2, RAP3, RAP4 and RAP5 + was 0%, 1%, 16%, 50% and 47%, respectively, suggesting that three or more episodes of AP is a strong risk factor for CP. Laboratory, imaging and clinical biomarkers highlighted that patients with RAP3 + do not show a significant difference between RAPs and CP. Data from CP registries showed 98% of patients had at least one AP and the average number of episodes was four. We mimicked the human RAPs in a mouse model and found that three or more episodes of AP cause early chronic-like morphological changes in the pancreas. We concluded that three or more attacks of AP with no morphological changes to the pancreas could be considered as early CP (ECP).The new diagnostic criteria for ECP allow the majority of CP patients to be diagnosed earlier. They can be used in hospitals with no additional costs in healthcare.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:
Scientific Reports. - 11 : 1 (2021), p. 1-14. -
További szerzők:
Soós Alexandra
Tóth Emese
Ébert Attila
Venglovecz Viktória
Márta Katalin
Mátrai Péter
Mikó Alexandra
Bajor Judit
Sarlós Patrícia
Vincze Áron
Halász Adrienn
Izbéki Ferenc
Szepes Zoltán
Czakó László
Kovács György (1982-) (belgyógyász, gasztroenterológus)
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Dubravcsik Zsolt (belgyógyász, gasztroenterológus)
Varga Márta
Hamvas József
Németh Balázs Csaba
Macarie, Melania
Ince, Ali Tüzün
Dubtsova, Elena A.
Kirynkova, Mariya A.
Khatkov, Igor E.
Bideeva, Tanya
Mickevicius, Artautas
Ramírez-Maldonado, Elena
Sallinen, Ville
Erős Bálint
Pécsi Dániel
Szentesi Andrea
Párniczky Andrea (gyermekgyógyász)
Tiszlavicz László
Hegyi Péter Jenő (belgyógyász)
Internet cím:
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
6.
001-es BibID:
BIBFORM101294
035-os BibID:
(cikkazonosító)e842 (wos)000804849400001
Első szerző:
Kui Balázs
Cím:
EASY-APP : an artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis / Kui Balázs, Pintér József, Molontay Roland, Nagy Marcell, Farkas Nelli, Gede Noémi, Vincze Áron, Bajor Judit, Gódi Szilárd, Czimmer József, Szabó Imre, Illés Anita, Sarlós Patrícia, Hágendorn Roland, Pár Gabriella, Papp Mária, Vitális Zsuzsanna, Kovács György, Fehér Eszter, Földi Ildikó, Izbéki Ferenc, Gajdán László, Fejes Roland, Németh Balázs Csaba, Török Imola, Farkas Hunor, Artautas Mickevicius, Ville Sallinen, Shamil Galeev, Elena Ramirez Maldonado, Párniczky Andrea, Erőss Bálint, Hegyi Péter Jenő, Márta Katalin, Váncsa Szilárd, Sutton Robert, Enrique de-Madaria, Elizabeth Pando, Piero Alberti, Maria José Gómez-Jurado, Alina Tantau, Szentesi Andrea, Hegyi Péter, Hungarian Pancreatic Study Group
Dátum:
2022
ISSN:
2001-1326
Megjegyzések:
Background: Acute pancreatitis (AP) is a potentially severe or even fatal inflammation of the pancreas. Early identification of patients, who are at high risk for developing a severe course of the disease is crucial for preventing organ failure and death. Most of the former predictive scores require many parameters or at least 24 hours to predict the severity, so the early therapeutic window is missing. Methods: The early achievable severity index (EASY) is a registered multicentre, multinational, prospective, observational study (ISRCTN10525246). Clinical parameters were collected from 15 countries and 28 medical centres via eCRF. The predictions were made using machine learning models including Decision Tree, Random Forest, Logistic Regression, SVM, CatBoost, and XGBoost. For the modeling, we used the scikit-learn, xgboost, and catboost Python packages. We have evaluated our models using 4-fold cross-validation and the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUC), and accuracy metrics have been calculated on the union of the test sets of the cross-validation. The most important factors and their contribution to the prediction were identified using a modern tool of explainable artificial intelligence, called SHapley Additive exPlanations (SHAP). Using the XGBoost machine learning algorithm for prediction, the SHAP values for the explanation, and the bootstrapping method for the estimation of confidence we have developed a web application in the Streamlit Python-based framework. Results: The prediction model is based on the international cohort of 1184 patients and a validation cohort of 3543 patients. The best performing model has been an XGBoost classifier with an average AUC score of 0.81 and accuracy of 89.1% and the model is improving with experience. The six most influential features are the respiratory rate, body temperature, abdominal muscular reflex, gender, age, and glucose level. Finally, a free and easy-to-use web application was developed (http://easy-app.org/). Conclusions: The EASY prediction score is a practical tool for identifying patients at high risk for severe acute pancreatitis within hours of hospital admission. The easy-to-use web application is available for clinicians and contributes to the improvement of the model.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
severity prediction
acute pancreatitis
artificial intelligence
Megjelenés:
Clinical and Translational Medicine. - 12 : 6 (2022), p. 1-13. -
További szerzők:
Pintér József (1930-) (urológus)
Molontay Roland
Nagy Marcell
Farkas Nelli
Gede Noémi
Vincze Áron
Bajor Judit
Gódi Szilárd
Czimmer József
Szabó Imre
Illés Anita
Sarlós Patrícia
Hágendorn Roland
Pár Gabriella
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Vitális Zsuzsanna (1963-) (belgyógyász, gasztroenterológus)
Kovács György (1982-) (belgyógyász, gasztroenterológus)
Fehér Eszter
Földi Ildikó (1981-) (orvos)
Izbéki Ferenc
Gajdán László
Fejes Roland
Németh Balázs Csaba
Török Imola
Farkas Hunor
Mickevicius, Artautas
Sallinen, Ville
Galeev, Shamil
Ramírez-Maldonado, Elena
Párniczky Andrea (gyermekgyógyász)
Erőss Bálint
Hegyi Péter Jenő (belgyógyász)
Márta Katalin
Váncsa Szilárd
Sutton, Robert
de-Madaria, Enrique
Pando, Elizabeth
Alberti, Piero
Gómez-Jurado, Maria José
Tantau, Alina
Szentesi Andrea
Hegyi Péter (pszichológus)
Hungarian Pancreatic Study Group
Internet cím:
Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:
Saját polcon:
7.
001-es BibID:
BIBFORM070012
035-os BibID:
e015874
Első szerző:
Márta Katalin
Cím:
High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial) : protocol of a multicentre randomized double-blind clinical trial / Katalin Márta, Anikó Nóra Szabó, Dániel Pécsi, Péter Varjú, Judit Bajor, Szilárd Gódi, Patrícia Sarlós, Alexandra Mikó, Katalin Szemes, Mária Papp, Tamás Tornai, Áron Vincze, Zsolt Márton, Patrícia Anna Vincze, Erzsébet Lankó, Andrea Szentesi, Tímea Molnár, Roland Hagendorn, Faluhelyi Nándor, István Battyáni, Dezső Kelemen, Róbert Papp, Attila Miseta, Verzár Zsófia, Markus M. Lerch, Johan P. Neoptoleomos, Miklós Sain-Tóth, Ole H. Petersen, Peter Hegyi
Dátum:
2017
ISSN:
2044-6055
Megjegyzések:
Introduction. Acute pancreatitis (AP) is an inflammatory disease with no specific therapy. Mitochondrial injury followed by ATP depletion in both acinar and ductal cells is a recently discovered early event in the pathogenesis. Importantly, preclinical research showed that intracellular ATP delivery restores the physiological function of the cells and protects from cell injury suggesting that restoration of energy levels in the pancreas is therapeutically beneficial. Despite several, high quality and experimental observations in this area, no randomized trials have been conducted to date to address the requirements for energy intake in the early phase of AP. Methods/Design. This is a randomized, controlled two-arms double-blind multicentre trial. Patients suffering from AP will be randomly assigned to groups A (30 kcal/kg/day energy administration starting within 24h of hospital admission) or B (low energy administration during the first 72h of hospital admission). Energy will be delivered with nasoenteric tube feeding with additional intravenous glucose supplementation or total parenteral nutrition if necessary. A combination of multi organ failure for more than 48h and mortality is defined as the primary endpoint, whereas several secondary endpoints such as length of hospitalization or pain will be determined to elucidate more detailed differences between the groups. The general feasibility, safety and quality checks required for high quality evidence will be adhered to.Ethics and Dissemination. The study has been approved by the relevant organization, The Scientific and Research Ethics Committee of the Hungarian Medical Research Council (55961- 2/2016/EKU). This study will provide evidence whether early high-energy nutritional support is beneficial in the clinical management of AP. The results of this trial will be published in an open access way and disseminated among medical doctors.Trial registration: The trial has been registered at the ISRCTN (ISRTCN 63827758).
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
acute pancreatitis
energy administration
enteral feeding
randomized clinical trial
Megjelenés:
BMJ Open. - 7 : 9 (2017), p. 1-9. -
További szerzők:
Szabó Anikó Nóra
Pécsi Dániel
Varjú Péter
Bajor Judit
Gódi Szilárd
Sarlós Patrícia
Mikó Alexandra
Szemes Katalin
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Tornai Tamás István (1984-) (belgyógyász)
Vincze Áron
Márton Zsolt
Vincze Patrícia Anna
Lankó Erzsébet
Szentesi Andrea
Molnár Tímea
Hágendorn Roland
Faluhelyi Nándor
Battyáni István
Kelemen Dezső
Papp Róbert
Miseta Attila
Verzár Zsófia
Lerch, Markus M.
Neoptoleomos, Johan P.
Sain-Tóth, Miklós
Petersen, Ole H.
Hegyi Péter Jenő (belgyógyász)
Pályázati támogatás:
GINOP-2.3.2-15-2016-00015
GINOP
KH-125678
NKFI
Internet cím:
Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:
Saját polcon:
8.
001-es BibID:
BIBFORM084964
Első szerző:
Mosztbacher Dóra
Cím:
Hypertriglyceridemia-induced acute pancreatitis : a prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases / Mosztbacher Dóra, Hanák Lilla, Farkas Nelli, Szentesi Andrea, Mikó Alexandra, Bajor Judit, Sarlós Patrícia, Czimmer József, Vincze Áron, Hegyi Péter Jenő, Erőss Bálint, Takács Tamás, Czakó László, Németh Balázs Csaba, Izbéki Ferenc, Halász Adrienn, Gajdán László, Hamvas József, Papp Mária, Földi Ildikó, Fehér Krisztina Eszter, Varga Márta, Csefkó Klára, Török Imola, Farkas Hunor Pál, Mickevicius Artautas, Maldonado Elena Ramirez, Sallinen Ville, Novák János, Ince Ali Tüzün, Galeev Shamil, Bod Barnabás, Sümegi János, Pencik Petr, Dubravcsik Zsolt, Illés Dóra, Gódi Szilárd, Kui Balázs, Márta Katalin, Pécsi Dániel, Varjú Péter, Szakács Zsolt, Darvasi Erika, Párniczky Andrea, Hegyi Péter Jr., Hungarian Pancreatic Study Group
Dátum:
2020
ISSN:
1424-3903
Megjegyzések:
Background. Hypertriglyceridemia is the third most common cause of acute pancreatitis (AP). It has been shown that hypertriglyceridemia aggravates the severity and related complications of AP; however, detailed analyses of large cohorts are inadequate and contradictory. Our aim was to investigate the dose-dependent effect of hypertriglyceridemia on AP. Methods. AP patients over 18 years old who underwent triglyceride measurement within the initial three days were included into our cohort analysis from a prospective international, multicenter AP registry operated by the Hungarian Pancreatic Study Group. Data on 716 AP cases were analyzed. Six groups were created based on the highest triglyceride level (<1.7 mmol/l, 1.7?2.19 mmol/l, 2.2?5.59 mmol/l, 5.6?11.29 mmol/l, 11.3?22.59 mmol/l, ?22.6 mmol/l). Results. Hypertriglyceridemia (?1.7 mmol/l) presented in 30.6% of the patients and was significantly and dose- dependently associated with younger age and male gender. In 7.7% of AP cases, hypertriglyceridemia (?11.3 mmol/l) was considered as a causative etiological factor; however, 43.6% of these cases were associated with other etiologies (alcohol and biliary). Hypertriglyceridemia was significantly and dose-dependently related to obesity and diabetes. The rates of local complications, organ failure and maximum CRP level were significantly and dose- dependently raised by hypertriglyceridemia. Triglyceride above 11.3 mmol/l was linked to a significantly higher incidence of moderately severe AP and longer hospital stay, whereas triglyceride over 22.6 mmol/l was significantly associated with severe AP as well. Conclusion. Hypertriglyceridemia dose-dependently aggravates the severity and related complications of AP. Diagnostic workup for hypertriglyceridemia requires better awareness regardless of the etiology of AP.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
acute pancreatitis
hypertriglyceridemia
etiology
cohort
severity
Megjelenés:
Pancreatology. - 20 : 4 (2020), p. 608-616. -
További szerzők:
Hanák Lilla
Farkas Nelli
Szentesi Andrea
Mikó Alexandra
Bajor Judit
Sarlós Patrícia
Czimmer József
Vincze Áron
Hegyi Péter Jenő (belgyógyász)
Erőss Bálint
Takács Tamás (Szeged)
Czakó László
Németh Balázs Csaba
Izbéki Ferenc
Halász Adrienn
Gajdán László
Hamvas József
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Földi Ildikó (1981-) (orvos)
Fehér Krisztina Eszter
Varga Márta
Csefkó Klára
Török Imola
Farkas Hunor
Mickevicius, Artautas
Maldonado, Elena Ramirez
Sallinen, Ville
Novák János
Ince, Ali Tüzün
Galeev, Shamil
Bod Barnabás
Sümegi János
Pencik, Petr
Dubravcsik Zsolt (belgyógyász, gasztroenterológus)
Illés Dóra
Gódi Szilárd
Kui Balázs
Márta Katalin
Pécsi Dániel
Varjú Péter
Szakács Zsolt
Darvasi Erika
Párniczky Andrea (gyermekgyógyász)
Hegyi Péter Jr. (belgyógyász)
Hungarian Pancreatic Study Group
Pályázati támogatás:
K131996
OTKA
FK131864
OTKA
FK124632
OTKA
K120335
OTKA
GINOP 2.3.2-15-2016-00048
GINOP
EFOP-3.6.2-16-2017-00006
EFOP
ÚNKP-19-4
ÚNKP
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
9.
001-es BibID:
BIBFORM103703
035-os BibID:
(cikkazonosító)2131 (Scopus)85130241509 (WoS)000803398400001
Első szerző:
Nagy Rita
Cím:
In-Hospital Patient Education Markedly Reduces Alcohol Consumption after Alcohol-Induced Acute Pancreatitis / Nagy Rita, Ocskay Klementina, Váradi Alex, Papp Mária, Vitális Zsuzsanna, Izbéki Ferenc, Boros Eszter, Gajdán László, Szentesi Andrea, Erőss Bálint, Hegyi Péter Jenő, Vincze Áron, Bajor Judit, Sarlos Patricia, Mikó Alexandra, Márta Katalin, Pécsi Dániel, Párniczky Andrea, Hegyi Péter
Dátum:
2022
ISSN:
2072-6643
Megjegyzések:
Although excessive alcohol consumption is by far the most frequent cause of recurrent acute pancreatitis (AP) cases, specific therapy is still not well established to prevent recurrence. Generally, psychological therapy (e.g., brief intervention (BI)) is the cornerstone of cessation programs; however, it is not yet widely used in everyday practice. We conducted a post-hoc analysis of a prospectively collected database. Patients suffering from alcohol-induced AP between 2016 and 2021 received 30 min BI by a physician. Patient-reported alcohol consumption, serum gamma-glutamyl-transferase (GGT) level, and mean corpuscular volume (MCV) of red blood cells were collected on admission and at the 1-month follow-up visit to monitor patients' drinking habits. Ninety-nine patients with alcohol-induced AP were enrolled in the study (mean age: 50 ? 11, 89% male). A significant decrease was detected both in mean GGT value (294 ? 251 U/L vs. 103 ? 113 U/L, p < 0.001) and in MCV level (93.7 ? 5.3 U/L vs. 92.1 ? 5.1 U/L, p < 0.001) in patients with elevated on-admission GGT levels. Notably, 79% of the patients (78/99) reported alcohol abstinence at the 1-month control visit. Brief intervention is an effective tool to reduce alcohol consumption and to prevent recurrent AP. Longitudinal randomized clinical studies are needed to identify the adequate structure and frequency of BIs in alcohol-induced AP
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:
Nutrients. - 14 : 10 (2022), p. 1-9. -
További szerzők:
Ocskay Klementina
Váradi Alex (1991-) (biológus)
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Vitális Zsuzsanna (1963-) (belgyógyász, gasztroenterológus)
Izbéki Ferenc
Boros Eszter
Gajdán László
Szentesi Andrea
Erőss Bálint
Hegyi Péter Jenő (belgyógyász)
Vincze Áron
Bajor Judit
Sarlós Patrícia
Mikó Alexandra
Márta Katalin
Pécsi Dániel
Párniczky Andrea (gyermekgyógyász)
Hegyi Péter (pszichológus)
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
10.
001-es BibID:
BIBFORM103700
035-os BibID:
(scopus)85121564971 (wos)000731322900016 (cikkazonosító)24158
Első szerző:
Ocskay Klementina
Cím:
Hypoalbuminemia affects one third of acute pancreatitis patients and is independently associated with severity and mortality / Ocskay Klementina, Vinkó Zsófia, Németh Dávid, Szabó László, Bajor Judit, Gódi Szilárd, Sarlós Patrícia, Czakó László, Izbéki Ferenc, Hamvas József, Papp Mária, Varga Márta, Török Imola, Mickevicius Artautas, Sallinen Ville, Maldonado Elena Ramirez, Galeev Shamil, Mikó Alexandra, Erőss Bálint, Imrei Marcell, Hegyi Péter Jenő, Faluhelyi Nándor, Farkas Orsolya, Kanizsai Péter, Miseta Attila, Nagy Tamás, Hágendorn Roland, Márton Zsolt, Szakács Zsolt, Szentesi Andrea, Hegyi Péter, Párniczky Andrea
Dátum:
2021
ISSN:
2045-2322
Megjegyzések:
The incidence and medical costs of acute pancreatitis (AP) are on the rise, and severe cases still have a 30% mortality rate. We aimed to evaluate hypoalbuminemia as a risk factor and the prognostic value of human serum albumin in AP. Data from 2461 patients were extracted from the international, prospective, multicentre AP registry operated by the Hungarian Pancreatic Study Group. Data from patients with albumin measurement in the frst 48 h (n= 1149) and anytime during hospitalization (n= 1272) were analysed. Multivariate binary logistic regression and Receiver Operator Characteristic curve analysis were used. The prevalence of hypoalbuminemia (<35 g/L) was 19% on admission and 35.7% during hospitalization. Hypoalbuminemia dose-dependently increased the risk of severity, mortality, local complications and organ failure and is associated with longer hospital stay. The predictive value of hypoalbuminemia on admission was poor for severity and mortality. Severe hypoalbuminemia (<25 g/L) represented an independent risk factor for severity (OR 48.761; CI 25.276?98.908) and mortality (OR 16.83; CI 8.32?35.13). Albumin loss during AP was strongly associated with severity (p< 0.001) and mortality (p= 0.002). Hypoalbuminemia represents an independent risk factor for severity and mortality in AP, and it shows a dose-dependent relationship with local complications, organ failure and length of stay.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:
Scientific Reports. - 11 : 1 (2021), p. 1-12. -
További szerzők:
Vinkó Zsófia
Németh Dávid
Szabó László
Bajor Judit
Gódi Szilárd
Sarlós Patrícia
Czakó László
Izbéki Ferenc
Hamvas József
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Varga Márta
Török Imola
Mickevicius, Artautas
Sallinen, Ville
Maldonado, Elena Ramirez
Galeev, Shamil
Mikó Alexandra
Erőss Bálint
Imrei Marcell
Hegyi Péter Jenő (belgyógyász)
Faluhelyi Nándor
Farkas Orsolya
Kanizsai Péter
Miseta Attila
Nagy Tamás
Hágendorn Roland
Márton Zsolt
Szakács Zsolt
Szentesi Andrea
Hegyi Péter (pszichológus)
Párniczky Andrea (gyermekgyógyász)
Pályázati támogatás:
EFOP-3.6.2-16-2017-00006
EFOP
GINOP-2.3.2-15-2016-00015
GINOP
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
11.
001-es BibID:
BIBFORM079249
Első szerző:
Párniczky Andrea (gyermekgyógyász)
Cím:
Antibiotic therapy in acute pancreatitis : from global overuse to evidence based recommendations / Andrea Parniczky, Tamas Lantos, Eszter Margit Toth, Zsolt Szakacs, Szilard Godi, Roland Hagendorn, Dora Illes, Balazs Koncz, Katalin Marta, Alexandra Miko, Dora Mosztbacher, Balazs Csaba Nemeth, Daniel Pecsi, Aniko Szabo, Akos Szücs, Peter Varjú, Andrea Szentesi, Erika Darvasi, Balint Eross, Ferenc Izbeki, Laszlo Gajdan, Adrienn Halasz, Aron Vincze, Imre Szabo, Gabriella Par, Judit Bajor, Patrícia Sarlos, Jozsef Czimmer, Jozsef Hamvas, Tamas Takacs, Zoltan Szepes, Laszlo Czako, Marta Varga, Janos Novak, Barnabas Bod, Attila Szepes, Janos Sümegi, Maria Papp, Csaba Gog, Imola Torok, Wei Huang, Qing Xia, Ping Xue, Weiqin Li, Weiwei Chen, Natalia V. Shirinskaya, Vladimir L. Poluektov, Anna V. Shirinskaya, Péter Jenő Hegyi, Marian Batovský, Juan Armando Rodriguez-Oballe, Isabel Miguel Salas, Javier Lopez-Diaz, J. Enrique Dominguez-Munoz, Xavier Molero, Elizabeth Pando, María Lourdes Ruiz-Rebollo, Beatriz Burgueno-Gomez, Yu-Ting Chang, Ming-Chu Chang, Ajay Sud, Danielle Moore, Robert Sutton, Amir Gougol, Georgios I. Papachristou, Yaroslav Mykhailovych Susak, Illia Olehovych Tiuliukin, Antonio Pedro Gomes, Maria Jesus Oliveira, David Joao Aparício, Marcel Tantau, Floreta Kurti, Mila Kovacheva-Slavova, Stephanie-Susanne Stecher, Julia Mayerle, Goran Poropat, Kshaunish Das, Marco Vito Marino, Gabriele Capurso, Ewa Małecka-Panas, Hubert Zatorski, Anita Gasiorowska, Natalia Fabisiak, Piotr Ceranowicz, Beata Kusnierz-Cabala, Joana Rita Carvalho, Samuel Raimundo Fernandes, Jae Hyuck Chang, Eun Kwang Choi, Jimin Han, Sara Bertilsson, Hanaz Jumaa, Gabriel Sandblom, Sabite Kacar, Minas Baltatzis, Aliaksandr Vladimir Varabei, Vizhynis Yeshy, Serge Chooklin, Andriy Kozachenko, Nikolay Veligotsky, Peter Jr. Hegyi, Hungarian Pancreatic Study Group
Dátum:
2019
ISSN:
1424-3903
Megjegyzések:
Background: Unwarranted administration of antibiotics in acute pancreatitis presents a global challenge. The clinical reasoning behind the misuse is poorly understood. Our aim was to investigate current clinical practices and develop recommendations that guide clinicians in prescribing antibiotic treatment in acute pancreatitis. Methods: Four methods were used. 1) Systematic data collection was performed to summarize current evidence; 2) a retrospective questionnaire was developed to understand the current global clinical practice; 3) five years of prospectively collected data were analysed to identify the clinical parameters used by medical teams in the decision making process, and finally; 4) the UpToDate Grading of Rec- ommendations, Assessment, Development and Evaluation (GRADE) system was applied to provide evi- dence based recommendations for healthcare professionals. Results: The systematic literature search revealed no consensus on the start of AB therapy in patients with no bacterial culture test. Retrospective data collection on 9728 patients from 22 countries indicated a wide range (31e82%) of antibiotic use frequency in AP. Analysis of 56 variables from 962 patients showed that clinicians initiate antibiotic therapy based on increased WBC and/or elevated CRP, lipase and amylase levels. The above mentioned four laboratory parameters showed no association with infection in the early phase of acute pancreatitis. Instead, procalcitonin levels proved to be a better biomarker of early infection. Patients with suspected infection because of fever had no benefit from antibiotic therapy. Conclusions: The authors formulated four consensus statements to urge reduction of unjustified anti- biotic treatment in acute pancreatitis and to use procalcitonin rather than WBC or CRP as biomarkers to guide decision-making.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
Acute pancreatitis
Antibiotic
Guideline
Recommendation
Infection
Megjelenés:
Pancreatology. - 19 : 4 (2019), p. 488-499. -
További szerzők:
Lantos Tamás
Tóth Eszter Margit
Szakács Zsolt
Gódi Szilárd
Hágendorn Roland
Illés Dóra
Koncz Balázs
Márta Katalin
Mikó Alexandra
Mosztbacher Dóra
Németh Balázs Csaba
Pécsi Dániel
Szabó Anikó
Szűcs Ákos (sebész)
Varjú Péter
Szentesi Andrea
Darvasi Erika
Erőss Bálint
Izbéki Ferenc
Gajdán László
Halász Adrienn
Vincze Áron
Szabó Imre (1952-) (orvos)
Pár Gabriella
Bajor Judit
Sarlós Patrícia
Czimmer József
Hamvas József
Takács Tamás (Szeged)
Szepes Zoltán
Czakó László
Varga Márta
Novák János
Bod Barnabás
Szepes Attila
Sümegi János
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Góg Csaba
Török Imola
Huang, Wei
Xia, Qing
Xue, Ping
Li, Weiqin
Chen, Weiwei
Shirinskaya, Natalia V.
Poluektov, Vladimir L.
Shirinskaya, Anna V.
Hegyi Péter Jenő (belgyógyász)
Bátovský, Marian
Rodriguez-Oballe, Juan Armando
Salas, Isabel Miguel
Lopez-Diaz, Javier
Dominguez-Munoz, J. Enrique
Molero, Xavier
Pando, Elizabeth
Ruiz-Rebollo, María Lourdes
Burgueño-Gómez, Beatriz
Chang, Yu-Ting
Chang, Ming-Chu
Sud, Ajay
Moore, Danielle
Sutton, Robert
Gougol, Amir
Papachristou, Georgios I.
Susak, Yaroslav Mykhailovych
Tiuliukin, Illia Olehovych
Gomes, António Pedro
Oliveira, Maria Jesus
Aparício, David João
Tantau, Marcel
Kurti, Floreta
Kovacheva-Slavova, Mila
Stecher, Stephanie-Susanne
Mayerle, Julia
Poropat, Goran
Das, Kshaunish
Marino, Marco Vito
Capurso, Gabriele
Małecka-Panas, Ewa
Zatorski, Hubert
Gasiorowska, Anita
Fabisiak, Natalia
Ceranowicz, Piotr
Kuśnierz-Cabala, Beata
Carvalho, Joana Rita
Fernandes, Samuel Raimundo
Chang, Jae Hyuck
Choi, Eun Kwang
Han, Jimin
Bertilsson, Sara
Jumaa, Hanaz
Sandblom, Gabriel
Kacar, Sabite
Baltatzis, Minas
Varabei, Aliaksandr Vladimir
Yeshy, Vizhynis
Chooklin, Serge
Kozachenko, Andriy
Veligotsky, Nikolay
Hegyi Péter Jr. (belgyógyász)
Hungarian Pancreatic Study Group
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
12.
001-es BibID:
BIBFORM082672
035-os BibID:
(cikkazonosító)1202 (WoS)000487293600001 (Scopus)85072974153
Első szerző:
Szentesi Andrea
Cím:
Multiple Hits in Acute Pancreatitis : Components of Metabolic Syndrome Synergize Each Other's Deteriorating Effects / Andrea Szentesi, Andrea Párniczky, Áron Vincze, Judit Bajor, Szilárd Gódi, Patricia Sarlós, Noémi Gede, Ferenc Izbéki, Adrienn Halász, Katalin Márta, Dalma Dobszai, Imola Török, Hunor Farkas, Mária Papp, Márta Varga, József Hamvas, János Novák, Artautas Mickevicius, Elena Ramirez Maldonado, Ville Sallinen, Dóra Illés, Balázs Kui, Bálint Erőss, László Czakó, Tamás Takács, Péter Jr. Hegyi, Hungarian Pancreatic Study Group
Dátum:
2019
ISSN:
1664-042X
Megjegyzések:
Introduction: The incidence of acute pancreatitis (AP) and the prevalence of metabolic syndrome (MetS) are growing worldwide. Several studies have confirmed that obesity (OB), hyperlipidemia (HL), or diabetes mellitus (DM) can increase severity, mortality, and complications in AP. However, there is no comprehensive information on the independent or joint effect of MetS components on the outcome of AP. Our aims were (1) to understand whether the components of MetS have an independent effect on the outcome of AP and (2) to examine the joint effect of their combinations. Methods: From 2012 to 2017, 1435 AP cases from 28 centers were included in the prospective AP Registry. Patient groups were formed retrospectively based on the presence of OB, HL, DM, and hypertension (HT). The primary endpoints were mortality, severity, complications of AP, and length of hospital stay. Odds ratio (OR) with 95% confidence intervals (CIs) were calculated. Results: 1257 patients (55.7 ? 17.0 years) were included in the analysis. The presence of OB was an independent predictive factor for renal failure [OR: 2.98 (CI: 1.33?6.66)] and obese patients spent a longer time in hospital compared to non-obese patients (12.1 vs. 10.4 days, p = 0.008). HT increased the risk of severe AP [OR: 3.41 (CI: 1.39?8.37)], renal failure [OR: 7.46 (CI: 1.61?34.49)], and the length of hospitalization (11.8 vs. 10.5 days, p = 0.020). HL increased the risk of local complications [OR: 1.51 (CI: 1.10?2.07)], renal failure [OR: 6.4 (CI: 1.93?21.17)], and the incidence of newly diagnosed DM [OR: 2.55 (CI: 1.26?5.19)]. No relation was found between the presence of DM and the outcome of AP. 906 cases (mean age ? SD: 56.9 ? 16.7 years) had data on all four components of MetS available. The presence of two, three, or four MetS factors increased the incidence of an unfavorable outcome compared to patients with no MetS factors. Conclusion: OB, HT, and HL are independent risk factors for a number of complications. HT is an independent risk factor for severity as well. Components of MetS strongly synergize each other's detrimental effect. It is important to search for and follow up on the components of MetS in AP.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
acute pancreatitis
metabolic syndrome
obesity
diabetes mellitus
hypertension
hyperlipidemia severity
mortality
Megjelenés:
Frontiers in Physiology. - 10 (2019), p. 1-13. -
További szerzők:
Párniczky Andrea (gyermekgyógyász)
Vincze Áron
Bajor Judit
Gódi Szilárd
Sarlós Patrícia
Gede Noémi
Izbéki Ferenc
Halász Adrienn
Márta Katalin
Dobszai Dalma
Török Imola
Farkas Hunor
Papp Mária (1975-) (belgyógyász, gasztroenterológus)
Varga Márta
Hamvas József
Novák János
Mickevicius, Artautas
Maldonado, Elena Ramirez
Sallinen, Ville
Illés Dóra
Kui Balázs
Erőss Bálint
Czakó László
Takács Tamás (Szeged)
Hegyi Péter Jr. (belgyógyász)
Hungarian Pancreatic Study Group
Pályázati támogatás:
KH125678
Egyéb
K116634
Egyéb
K120335
Egyéb
K128222
Egyéb
GINOP 2.3.2-15-2016-00048
GINOP
EFOP-3.6.2-16-2017-00006
EFOP
LP2014-10/2014
Egyéb
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
Rekordok letöltése
1
Corvina könyvtári katalógus v8.2.27
© 2023
Monguz kft.
Minden jog fenntartva.